A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants
study id #: NCT00418821
condition: Mucopolysaccharidosis I, Hurler's Syndrome, Hurler-Scheie Syndrome, Scheie
status: Recruiting
purpose:The purpose of this study is to determine if laronidase is present in the breast milk of post-partum women receiving Aldurazyme® (laronidase) and the effects of Aldurazyme (laronidase) on the growth, development, and immunologic response of their breastfed infants.
intervention: Aldurazyme (laronidase)
results: https://clinicaltrials.gov/ct2/show/results/NCT00418821
last updated: February 26, 2022
-
Hearing Loss in MucopolysaccharidosisIntroduction: Mucopolysaccharidosis (MPS...
-
Iminosugar C-Glycosides Work as Pharmacological Chaperones of NAGLU, a Glycosidase Involved in MPS IIIB Rare DiseaseMucopolysaccharidosis type IIIB is a dev...
-
MPS I: Early Diagnosis, Bone Disease and Treatment, Where Are We NowMucopolysaccharidosis type I (MPS I) is ...
-
Identification and Structure Characterization of Novel IDS Variants Causing Mucopolysaccharidosis Type II: A Retrosp...Mucopolysaccharidosis type II (MPS II) o...
-
Mucopolysaccharidoses (MPS) and Gene TherapyMucopolysaccharidoses (MPS) are a group ...
-
MPS and Other Similar Lysosomal DiseasesMucopolysaccharidosis (MPS) and other si...
-
Angle-Closure Glaucoma With Attenuated Mucopolysaccharidosis Type I in a Chinese FamilyMPS I is a metabolic disease that involv...